Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics -  - Books - Springer International Publishing AG - 9783319888910 - June 23, 2018
In case cover and title do not match, the title is correct

Resistance to Targeted Therapies in Breast Cancer - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2017 edition

Price
$ 112.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 16 - 22
Add to your iMusic wish list

Not rated yet

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).


184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released June 23, 2018
ISBN13 9783319888910
Publishers Springer International Publishing AG
Pages 184
Dimensions 150 × 220 × 10 mm   ·   290 g
Language German  
Editor Prosperi, Jenifer R.

Mere med samme udgiver